John Turnidge

University of Adelaide

Papers

2

Total Citations

27

H-Index

2

About

John Turnidge is a leading figure in antimicrobial resistance (AMR) surveillance and clinical microbiology, whose work bridges laboratory innovation and global health policy. His key research areas include the epidemiology of antimicrobial resistance, One Health surveillance, and the development of high-throughput diagnostic tools. Turnidge’s major contribution is the creation of the Robotic Antimicrobial Susceptibility Platform (RASP), a next-generation system that dramatically scales up AMR monitoring by automating susceptibility testing across human, animal, and environmental samples. This breakthrough addresses a critical bottleneck in surveillance—sample size limitations—enabling more robust, real-time data collection. His most cited paper on RASP (2021, 24 citations) has already influenced the design of national and international AMR monitoring programs. Beyond this, Turnidge has been instrumental in setting clinical breakpoints for antimicrobial agents and shaping guidelines for resistance detection. His work is widely cited by researchers in infectious disease, public health, and veterinary science, reflecting its cross-sector impact. A sought-after collaborator, Turnidge continues to drive innovation in AMR surveillance, making him a pivotal voice in the fight against drug-resistant infections.

Research Focus

Key Achievements

2
H-Index
2
Papers
27
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
Robotic Antimicrobial Susceptibility Platform (RASP): a next-generation approach to One Health surveillance of antimicrobial resistance
24 citations · 2021
📈 Most Prolific Year: 2021 (2 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: University of Adelaide

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago